| Pharmaceutical Information |
| Drug Name |
Thallous chloride |
| Drug ID |
BADD_D02193 |
| Description |
Thallous chloride (also known as Thallium(I) chloride) is a colourless solid intermediate in the isolation of thallium from its ores. It is created from the treatment of thallium(I) sulfate with hydrochloric acid. This solid crystallizes in the caesium chloride motif. It is used as a diagnostic radiopharmaceutical. It is used for diagnosis of heart and parathyroid problems. The following are among the possible side effects: Blurred vision, chest pain or discomfort, chills, confusion, cough, difficulty with breathing, difficulty with swallowing, and dizziness. |
| Indications and Usage |
For use as a diagnostic radiopharmaceutical.
It is indicated to help diagnose heart disease (eg, coronary artery disease, heart attack). It is also used for the diagnosis of parathyroid problems. |
| Marketing Status |
approved |
| ATC Code |
Not Available |
| DrugBank ID |
DB09316
|
| KEGG ID |
Not Available
|
| MeSH ID |
C027549
|
| PubChem ID |
24642
|
| TTD Drug ID |
Not Available
|
| NDC Product Code |
Not Available |
| UNII |
37CB58V15B
|
| Synonyms |
thallium chloride | thallium monochloride | thallous chloride | thallium chloride, (205)Tl,(37)Cl-labeled | thallium chloride, (203)Tl,(37)Cl-labeled | thallium chloride, (205)Tl,(35)Cl-labeled | thallium chloride, (201)Tl-labeled | thallium chloride, (203)Tl,(35)Cl-labeled |
|
| Chemical Information |
| Molecular Formula |
ClTl |
| CAS Registry Number |
7791-12-0 |
| SMILES |
Cl[Tl] |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
|
|
|
